Lupus Research Alliance-Bristol Myers Squibb (BMS) Partnership
The Lupus Research Alliance-Bristol-Myers Squibb (BMS) partnership was enabled by a generous $3 million gift from BMS. This collaboration supports 10 innovative projects through a dedicated grant mechanism, the Accelerator Award. These projects focus on understanding the underlying causes of systemic and cutaneous lupus, exploring human lupus heterogeneity and identifying novel biomarkers. The research is conducted in close collaboration with a Lupus Research Alliance-BMS Joint Steering Committee comprised of BMS scientists and Lupus Research Alliance-appointed external experts.
Pfizer’s Centers for Therapeutic Innovation (CTI)
In 2012, the Lupus Research Alliance became Pfizer’s Centers for Therapeutic Innovation’s (CTI’s) first foundation partner. Since then, the initiative has supported nearly a dozen studies advancing pre-clinical and early stage clinical drug candidates for the treatment of SLE.
